LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study
Benjamin Musher(Baylor College of Medicine), Angelica Loskog(Uppsala University), Eric K. Rowinsky(The University of Texas at San Antonio), Salmaan Jawaid(Baylor College of Medicine), Ann M. Leen(Texas Children's Hospital), Brandon G. Smaglo(The University of Texas MD Anderson Cancer Center), Gustav Ullenhag(Uppsala University), Amanda Brisco(University of South Florida), Linda C. Sandin, Malcolm K. Brenner(Houston Methodist), Wasif M. Abidi(Baylor College of Medicine), Mohamed O. Othman(Baylor College of Medicine), Meng-Fen Wu(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), James Jing(Baylor College of Medicine), Justyna Leja-Jarblad, Kalpesh Patel(Baylor College of Medicine), Bambi Grilley(Baylor College of Medicine), Emma Eriksson(Uppsala University), Jessica Wenthe(Uppsala University)
Cited by 64
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
|Blood|2003|442
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
|Science|2011|440
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440